Drug · DIN 02446324
QNASL
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since November 16, 2023.
- Drug Identification Number (DIN)
- 02446324
- Company (DIN owner)
- Teva Canada LimitedToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Metered-Dose Aerosol
- Route
- Nasal
- Therapeutic class (ATC)
- Beclomethasone R01AD01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BECLOMETHASONE DIPROPIONATE | 40 MCG | ACT |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 18, 2015: NOC 17285New Drug Submission (NDS)
Other DINs named QNASL
- DIN 02446332 · Cancelled Pre Market